
Targeted Magnetic Stimulation Slows Alzheimer’s Progression: Phase II Study
A Phase II study conducted over fifty-two weeks shows that personalized rTMS targeting the Default Mode Network significantly slows the progression of Alzheimer’s disease while improving both cognitive and daily functions without any significant side effects. According to a recent Phase II clinical research, Alzheimer’s disease development can be markedly slowed by focused magnetic stimulation,…